AU2010204766B2 - Methods for improving hepatic and immune function in an animal - Google Patents
Methods for improving hepatic and immune function in an animal Download PDFInfo
- Publication number
- AU2010204766B2 AU2010204766B2 AU2010204766A AU2010204766A AU2010204766B2 AU 2010204766 B2 AU2010204766 B2 AU 2010204766B2 AU 2010204766 A AU2010204766 A AU 2010204766A AU 2010204766 A AU2010204766 A AU 2010204766A AU 2010204766 B2 AU2010204766 B2 AU 2010204766B2
- Authority
- AU
- Australia
- Prior art keywords
- lipoic acid
- ppm
- composition
- salt
- immune function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/353,351 US20090176864A1 (en) | 2004-11-24 | 2009-01-14 | Methods For Improving Hepatic and Immune Function In An Animal |
US12/353,351 | 2009-01-14 | ||
PCT/US2010/020993 WO2010083277A2 (en) | 2009-01-14 | 2010-01-14 | Methods for improving hepatic and immune function in an animal |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2010204766A1 AU2010204766A1 (en) | 2011-07-21 |
AU2010204766B2 true AU2010204766B2 (en) | 2013-01-31 |
Family
ID=42124569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010204766A Active AU2010204766B2 (en) | 2009-01-14 | 2010-01-14 | Methods for improving hepatic and immune function in an animal |
Country Status (12)
Country | Link |
---|---|
US (2) | US20090176864A1 (ja) |
EP (1) | EP2387325B1 (ja) |
JP (1) | JP5791520B2 (ja) |
CN (2) | CN106036037A (ja) |
AU (1) | AU2010204766B2 (ja) |
BR (1) | BRPI1007294A2 (ja) |
CA (2) | CA2843448A1 (ja) |
DK (1) | DK2387325T3 (ja) |
ES (1) | ES2603986T3 (ja) |
RU (1) | RU2485797C2 (ja) |
WO (1) | WO2010083277A2 (ja) |
ZA (1) | ZA201104624B (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
CA2588709C (en) * | 2004-11-24 | 2015-07-14 | Hill's Pet Nutrition, Inc. | Use of lipoic acid to improve hepatic clearance of xenobiotic substances |
CN104304671A (zh) | 2004-12-29 | 2015-01-28 | 希尔氏宠物营养品公司 | 抑制动物学习和/或记忆减退的方法 |
CA2592844C (en) * | 2004-12-30 | 2012-10-09 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
US8722112B2 (en) * | 2005-07-14 | 2014-05-13 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
CN105639121A (zh) * | 2009-07-14 | 2016-06-08 | 希尔氏宠物营养品公司 | 包括持续释放的硫辛酸的宠物食品组合物及其制造和使用方法 |
CN102657297A (zh) * | 2012-05-30 | 2012-09-12 | 扬州大学 | 一种调控高产奶牛围产期氧化应激的方法 |
US20210369661A1 (en) * | 2020-05-27 | 2021-12-02 | Immunoflex Therapeutics Inc. | Methods and compositions for treating and recovering from viral infections |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5621117A (en) * | 1994-07-30 | 1997-04-15 | Asta Medica Aktiengesellschaft | Method for the racemization of enantiomers of α-lipoic acid |
US5994393A (en) * | 1998-03-11 | 1999-11-30 | Asta Medica Aktiengesellschaft | Alpha-lipoic acid with novel modification |
US6197340B1 (en) * | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
US20020076469A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US20030224061A1 (en) * | 2002-06-04 | 2003-12-04 | Pacioretty Linda M. | Oral composition with insulin-like activities and methods of use |
US20040138311A1 (en) * | 2001-05-28 | 2004-07-15 | Michael Taeger | Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus |
US20050123628A1 (en) * | 2003-12-03 | 2005-06-09 | George Zabrecky | Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis |
US6914071B2 (en) * | 2000-10-31 | 2005-07-05 | Colgate-Palmolive Company | Antioxidant containing composition and method |
WO2006058248A2 (en) * | 2004-11-24 | 2006-06-01 | Hill's Pet Nutrition, Inc. | Methods for increasing the immune response in an animal |
KR20060072603A (ko) * | 2004-12-23 | 2006-06-28 | 한서제약 주식회사 | α-리포산 함유 간질환 예방 또는 치료용 조성물 |
KR20070025426A (ko) * | 2005-09-02 | 2007-03-08 | 부광약품 주식회사 | D-(+)-α-리포산 트로메타민염을 포함하는 간섬유화 억제 및 치료용 조성물 |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2980716A (en) * | 1954-06-11 | 1961-04-18 | Research Corp | Method for preparing 6, 8-dihalooctanoic esters |
US2890716A (en) * | 1956-03-16 | 1959-06-16 | Buensod Stacey Inc | Control device |
US3202514A (en) * | 1963-07-15 | 1965-08-24 | Gen Foods Corp | Animal food and method of making the same |
US6090414A (en) * | 1970-05-20 | 2000-07-18 | Life Science Labs, Inc. | Method and composition to reduce cancer incidence |
US3946123A (en) * | 1975-03-10 | 1976-03-23 | Star-Kist Foods, Inc. | Canned pet food |
US4053647A (en) * | 1975-12-12 | 1977-10-11 | Samuel Prussin | Pet food product and process of producing such |
US4247562A (en) * | 1978-12-21 | 1981-01-27 | The Quaker Oats Company | Moist pet food with blood chunks and a fluid gravy system |
DE3378909D1 (en) * | 1982-10-20 | 1989-02-16 | Takeda Chemical Industries Ltd | Physiologically active substance p-23924, its production and use |
US5004624A (en) * | 1983-03-14 | 1991-04-02 | Star-Kist Foods, Inc. | Semi-moist pet food having free gravy and process for preparation thereof |
EP0270690B1 (en) * | 1986-06-21 | 1991-05-15 | Dainippon Ink And Chemicals, Inc. | Drug for treatment and prophylaxis of kidney and liver diseases |
US5030458A (en) * | 1989-11-27 | 1991-07-09 | Shug Austin L | Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |
US4997672A (en) * | 1987-03-10 | 1991-03-05 | Virginia Commonwealth University | Salt taste enhancer |
ES2043897T3 (es) * | 1988-01-28 | 1994-01-01 | Koeltringer Peter | Preparado de combinacion, en especial para el tratamiento de enfermedades de las celulas nerviosas. |
US6977167B2 (en) * | 1988-09-07 | 2005-12-20 | Martek Biosciences Corporation | Mixtures of omega-3 and omega-6 highly unsaturated fatty acids from euryhaline microorganisms |
US4997671A (en) * | 1988-09-09 | 1991-03-05 | Nabisco Brands, Inc. | Chewy dog snacks |
US5114704A (en) * | 1989-05-30 | 1992-05-19 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
IE904034A1 (en) * | 1989-11-09 | 1991-05-22 | Asta Medica Ag | A medicament containing r-ó-lipoic acid or s-ó-lipoic acid¹as active substance |
US6746678B1 (en) * | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
US5419283A (en) * | 1992-04-08 | 1995-05-30 | Ciuffo Gatto S.R.L. | Animal chew toy of starch material and degradable ethylene copolymer |
US5569670A (en) * | 1992-06-05 | 1996-10-29 | Asta Medica Aktiengesellschaft | Combination medications containing alpha-lipoic acid and related |
US5624896A (en) * | 1992-06-09 | 1997-04-29 | Neorx Corporation | Clearing agents useful in pretargeting methods |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
DE4235912C2 (de) * | 1992-10-23 | 2002-12-05 | Viatris Gmbh | Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung |
JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
US5532010A (en) * | 1993-05-28 | 1996-07-02 | Nabisco, Inc. | Coated canine biscuits and preparation process |
US5339771A (en) * | 1993-09-15 | 1994-08-23 | Axelrod Herbert R | Animal chew toy containing animal meal |
WO1995013824A1 (en) * | 1993-11-15 | 1995-05-26 | Celtrix Pharmaceuticals, Inc. | Method of treating renal disease by administering igf-i and igfbp-3 |
US6458767B1 (en) * | 1994-05-04 | 2002-10-01 | The Uab Research Foundation | Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease |
US5599835A (en) * | 1994-11-23 | 1997-02-04 | Fischer; Frederick B. | Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus |
US5621177A (en) * | 1995-03-02 | 1997-04-15 | Yokogawa Electric Corporation | Electromagnetic flowmeter |
US5730988A (en) * | 1995-04-20 | 1998-03-24 | Lynntech, Inc. | Nutritional supplements for improving glucose metabolism |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
FR2738741B1 (fr) * | 1995-09-19 | 1997-12-05 | Oreal | Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p |
CA2208392C (en) * | 1996-06-21 | 2002-09-03 | University Of Guelph | Method for enriching docosahexaenoic acid in expressed milk of dairy cattle |
US5965596A (en) * | 1997-08-12 | 1999-10-12 | Harris; Roger | Methods and compositions for increasing the anaerobic working capacity in tissue |
US6190591B1 (en) * | 1996-10-28 | 2001-02-20 | General Mills, Inc. | Embedding and encapsulation of controlled release particles |
US6232346B1 (en) * | 1997-03-27 | 2001-05-15 | Michael J. Sole | Composition for improvement of cellular nutrition and mitochondrial energetics |
US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
US6133323A (en) * | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
US5883083A (en) * | 1997-06-09 | 1999-03-16 | Harlmen, Inc. | Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines |
US5916912A (en) * | 1997-06-16 | 1999-06-29 | The Regents Of The University Of California | Dietary composition for enhancing metabolism and alleviating oxidative stress |
US6039952A (en) * | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
US6365623B1 (en) * | 1997-11-17 | 2002-04-02 | Nicholas V. Perricone | Treatment of acne using lipoic acid |
US6117477A (en) * | 1998-03-18 | 2000-09-12 | Kal Kan Foods, Inc. | Multicomponent food product and methods of making and using the same |
DE19834608A1 (de) * | 1998-07-31 | 2000-02-03 | Basf Ag | Kristallmodifikation der Liponsäure |
US6136339A (en) * | 1998-08-21 | 2000-10-24 | Gardiner; Paul T. | Food supplements and methods comprising lipoic acid and creatine |
IT1302307B1 (it) * | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
AUPP784398A0 (en) * | 1998-12-21 | 1999-01-21 | Monash University | Kidney disease detection and treatment |
BR9916407A (pt) * | 1998-12-21 | 2001-09-25 | Univ Monash | Detecção e tratamento de doenças dos rins |
US20040029175A1 (en) * | 1998-12-21 | 2004-02-12 | Comper Wayne D. | Method for kidney disease detection |
US6284786B1 (en) * | 1999-02-16 | 2001-09-04 | The Center For The Improvement Of Human Functioning, Int'l., Inc. | Treatment of cancer using lipoic acid in combination with ascorbic acid |
DK1033364T3 (da) * | 1999-03-01 | 2005-06-06 | Pfizer Prod Inc | Cyanholdige oxamidsyrer og -derivater som thyroideareceptorligander |
IT1306130B1 (it) * | 1999-04-16 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti. |
ATE301937T1 (de) * | 1999-05-27 | 2005-09-15 | Iams Company | Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien |
US6365211B1 (en) * | 1999-06-18 | 2002-04-02 | The Procter & Gamble Co. | Cooking aid with reduced foaming |
US6426362B1 (en) * | 1999-10-08 | 2002-07-30 | Galileo Laboratories, Inc. | Formulations of tocopherols and methods of making and using them |
IL149421A0 (en) * | 1999-11-02 | 2002-11-10 | Depomed Inc | Pharmaceutical compositions containing fed mode inducing agents |
WO2001032168A1 (en) * | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
US6379727B1 (en) * | 1999-12-29 | 2002-04-30 | John F. Addy | Flavoring system for pet foods |
US20030060503A1 (en) * | 2000-01-25 | 2003-03-27 | Juvenon, Inc. | Nutritional supplements for mature pets |
KR20020090214A (ko) * | 2000-02-01 | 2002-11-30 | 머슬테크 리서치 앤드 디벨롭먼트, 인크. | 근육을 키우거나 강도를 늘리기 위한 α리포산계의보조식품 |
JP4487376B2 (ja) * | 2000-03-31 | 2010-06-23 | 味の素株式会社 | 腎疾患治療剤 |
US7067145B2 (en) * | 2000-09-07 | 2006-06-27 | University Of Maryland Biotechnology Institute | Use of arachidonic acid for enhanced culturing of fish larvae and broodstock |
US6784159B2 (en) * | 2000-09-29 | 2004-08-31 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture | Triterpene saponins from soybeans for treating kidney disease |
US6277842B1 (en) * | 2000-10-17 | 2001-08-21 | James Alexander Carthron | Dietary supplemental method for fat and weight reduction |
US20020115710A1 (en) * | 2000-10-31 | 2002-08-22 | Zicker Steven Curtis | Composition and method |
US8592479B2 (en) * | 2000-10-31 | 2013-11-26 | Hill's Pet Nutrition, Inc. | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
US20090156658A1 (en) * | 2000-10-31 | 2009-06-18 | Hill's Pet Nutrition, Inc. | Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals |
JP2004514686A (ja) * | 2000-10-31 | 2004-05-20 | コルゲート・パーモリブ・カンパニー | 組成物と方法 |
US20020052402A1 (en) * | 2000-10-31 | 2002-05-02 | Colgate-Palmolive Company | Composition and method |
US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
DE60039726D1 (de) * | 2000-12-29 | 2008-09-11 | Martin Francis Gannon | Tiernahrungsmittelzusammensetzung |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
CA2439078C (en) * | 2001-03-09 | 2009-08-25 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
CA2446027C (en) * | 2001-05-14 | 2009-04-28 | Martek Biosciences Corporation | A method of improving the flavor, tenderness and overall consumer acceptability of poultry meat |
US6596762B2 (en) * | 2001-05-17 | 2003-07-22 | The Regents Of The University Of Colorado | Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis |
US6596768B2 (en) * | 2001-05-22 | 2003-07-22 | Church & Dwight Co., Inc. | Unsaturated lipid-enriched feedstock for ruminants |
US6902739B2 (en) * | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
GB0119052D0 (en) * | 2001-08-03 | 2001-09-26 | Mars Uk Ltd | Foodstuff |
DE10151764A1 (de) * | 2001-10-19 | 2003-05-08 | Basf Ag | Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln |
US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
US20030194478A1 (en) * | 2002-04-12 | 2003-10-16 | Davenport Gary Mitchell | Dietary methods for canine performance enhancement |
US8841344B2 (en) * | 2002-10-03 | 2014-09-23 | Hill's Pet Nutrition, Inc. | Method of using omega-3 fatty acids |
CA2525560A1 (en) * | 2003-05-13 | 2004-11-25 | The Regents Of The University Of Colorado | Diagnostic and therapeutic treatments related to mitochondrial disorders |
US7202270B2 (en) * | 2003-06-20 | 2007-04-10 | Sami Labs Limited | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses |
WO2006012267A1 (en) * | 2004-06-29 | 2006-02-02 | Elixirin Corporation | Dietary compositions for enhancing metabolism and reducing reactive oxygen species |
US20060002985A1 (en) * | 2004-07-02 | 2006-01-05 | Zicker Steven C | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
CA2588709C (en) * | 2004-11-24 | 2015-07-14 | Hill's Pet Nutrition, Inc. | Use of lipoic acid to improve hepatic clearance of xenobiotic substances |
US8168161B2 (en) * | 2004-12-22 | 2012-05-01 | Hill's Pet Nutrition, Inc. | Method to promote oral health in companion animals |
CN104304671A (zh) * | 2004-12-29 | 2015-01-28 | 希尔氏宠物营养品公司 | 抑制动物学习和/或记忆减退的方法 |
US8722112B2 (en) * | 2005-07-14 | 2014-05-13 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
BRPI0615211A2 (pt) * | 2005-08-17 | 2013-01-15 | Hills Pet Nutrition Inc | composiÇço, mÉtodo para evitar ou tratar doenÇa renal ou para a melhora da funÇço renal, kit, e, meio para comunicar informaÇço sobre ou instruÇÕes para a mistura e administraÇço de um ou mais das composiÇÕes, componentes de composiÇço, composiÇÕes alimentÍcias, ingredientes alimentÍcios e medicamentos renais e para uso dos dispositivos de diagnàstico renal |
KR100811110B1 (ko) * | 2007-02-21 | 2008-03-06 | 주식회사 디피아이 솔루션스 | 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법. |
-
2009
- 2009-01-14 US US12/353,351 patent/US20090176864A1/en not_active Abandoned
-
2010
- 2010-01-14 AU AU2010204766A patent/AU2010204766B2/en active Active
- 2010-01-14 BR BRPI1007294-2A patent/BRPI1007294A2/pt not_active Application Discontinuation
- 2010-01-14 CN CN201610320105.4A patent/CN106036037A/zh active Pending
- 2010-01-14 ES ES10700915.1T patent/ES2603986T3/es active Active
- 2010-01-14 WO PCT/US2010/020993 patent/WO2010083277A2/en active Application Filing
- 2010-01-14 RU RU2011134077/13A patent/RU2485797C2/ru not_active IP Right Cessation
- 2010-01-14 EP EP10700915.1A patent/EP2387325B1/en active Active
- 2010-01-14 DK DK10700915.1T patent/DK2387325T3/en active
- 2010-01-14 CA CA2843448A patent/CA2843448A1/en not_active Abandoned
- 2010-01-14 CN CN2010800048871A patent/CN102281769A/zh active Pending
- 2010-01-14 CA CA2749280A patent/CA2749280C/en active Active
- 2010-01-14 JP JP2011546323A patent/JP5791520B2/ja active Active
-
2011
- 2011-02-17 US US13/029,503 patent/US20110135785A1/en not_active Abandoned
- 2011-06-22 ZA ZA2011/04624A patent/ZA201104624B/en unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5621117A (en) * | 1994-07-30 | 1997-04-15 | Asta Medica Aktiengesellschaft | Method for the racemization of enantiomers of α-lipoic acid |
US5994393A (en) * | 1998-03-11 | 1999-11-30 | Asta Medica Aktiengesellschaft | Alpha-lipoic acid with novel modification |
US6197340B1 (en) * | 1998-05-28 | 2001-03-06 | Medical Research Institute | Controlled release lipoic acid |
US20020076469A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US6914071B2 (en) * | 2000-10-31 | 2005-07-05 | Colgate-Palmolive Company | Antioxidant containing composition and method |
US20040138311A1 (en) * | 2001-05-28 | 2004-07-15 | Michael Taeger | Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus |
US20030224061A1 (en) * | 2002-06-04 | 2003-12-04 | Pacioretty Linda M. | Oral composition with insulin-like activities and methods of use |
US20050123628A1 (en) * | 2003-12-03 | 2005-06-09 | George Zabrecky | Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis |
WO2006058248A2 (en) * | 2004-11-24 | 2006-06-01 | Hill's Pet Nutrition, Inc. | Methods for increasing the immune response in an animal |
KR20060072603A (ko) * | 2004-12-23 | 2006-06-28 | 한서제약 주식회사 | α-리포산 함유 간질환 예방 또는 치료용 조성물 |
KR20070025426A (ko) * | 2005-09-02 | 2007-03-08 | 부광약품 주식회사 | D-(+)-α-리포산 트로메타민염을 포함하는 간섬유화 억제 및 치료용 조성물 |
Non-Patent Citations (3)
Title |
---|
CUI, J. et al., Cellular Immunology, 2009, 260, 44-50 * |
LEY, B. M., http://web.archive.org/web/20000614235007/http://www.tldp.com/issue/160/160alpha.htm, 14 June 2000 * |
OHMORI, H. et al., Japan J. Pharmacol., 1986, 42, 275-280 * |
Also Published As
Publication number | Publication date |
---|---|
CN102281769A (zh) | 2011-12-14 |
EP2387325B1 (en) | 2016-08-17 |
US20110135785A1 (en) | 2011-06-09 |
CN106036037A (zh) | 2016-10-26 |
ES2603986T3 (es) | 2017-03-02 |
JP2012515211A (ja) | 2012-07-05 |
CA2749280A1 (en) | 2010-07-22 |
WO2010083277A2 (en) | 2010-07-22 |
RU2485797C2 (ru) | 2013-06-27 |
ZA201104624B (en) | 2015-02-25 |
EP2387325A2 (en) | 2011-11-23 |
RU2011134077A (ru) | 2013-02-20 |
JP5791520B2 (ja) | 2015-10-07 |
DK2387325T3 (en) | 2016-12-05 |
WO2010083277A3 (en) | 2011-01-06 |
US20090176864A1 (en) | 2009-07-09 |
AU2010204766A1 (en) | 2011-07-21 |
BRPI1007294A2 (pt) | 2015-08-25 |
CA2749280C (en) | 2014-05-06 |
CA2843448A1 (en) | 2010-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010204766B2 (en) | Methods for improving hepatic and immune function in an animal | |
Baetz et al. | Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. | |
Sadahira et al. | Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. | |
Alvarez et al. | ER to Golgi transport: requirement for p115 at a pre-Golgi VTC stage | |
Nau | The methylation of tRNA | |
Kirchhoff et al. | Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation | |
Reid et al. | Red blood cell blood group antigens: structure and function | |
Niehaus et al. | Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration | |
Hwang et al. | Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons | |
Wuytack et al. | The Ca 2+-transport ATPases from the plasma membrane | |
Weerth et al. | Signaling proteins in raft-like microdomains are essential for Ca2+ wave propagation in glial cells | |
Gibbs et al. | Glioma pathogenesis-related 1-like 1 is testis enriched, dynamically modified, and redistributed during male germ cell maturation and has a potential role in sperm-oocyte binding | |
Markova et al. | Sodium/calcium exchanger is upregulated by sulfide signaling, forms complex with the β1 and β3 but not β2 adrenergic receptors, and induces apoptosis | |
Bast et al. | Idiotypic peripheral blood lymphocytes in monoclonal gammopathy | |
Lawrence et al. | Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes | |
Tiengwe et al. | Surface proteins, ERAD and antigenic variation in Trypanosoma brucei | |
Shigeri et al. | Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line. | |
Choi et al. | Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells | |
Van Lier et al. | T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways | |
Foster et al. | Markers of the metastatic phenotype in prostate cancer | |
Crouch et al. | Insulin induces epidermal growth factor (EGF) receptor clustering and potentiates EGF‐stimulated DNA synthesis in Swiss 3T3 cells: a mechanism for costimulation in mitogenic synergy | |
Piontek et al. | Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: evidence that gravin provides a dynamic platform for the localization of kinases during neuronal development | |
AU680198B2 (en) | Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against them | |
Mahabaleshwar et al. | Slit‐Robo signalling establishes a Sphingosine‐1‐phosphate gradient to polarise fin mesenchyme | |
Pain | Protein synthesis in a postmitochondrial supernatant system from rat liver. An effect of diabetes at the level of peptide chain initiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |